Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.52 |
| ▸ | NPC1 | O15118 | 5/20 | 0.49 |
| ▸ | RAB9A | P51151 | 5/20 | 0.49 |
| ▸ | HPGD | P15428 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | LMNA | P02545 | 4/20 | 0.49 |
| ▸ | TP53 | P04637 | 3/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.47 |
| ▸ | PKM | P14618 | 2/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.47 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | AURKA | O14965 | 1/20 | 0.47 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11827448 | 0.88 | KDM4E (0.55) | CDC25BKDM4ENPC1RAB9AHPGD | |
| SCHEMBL18053137 | 0.84 | KDM4E (0.49) | KDM4ENPC1RAB9AHPGDSMN1; SMN2 | |
| SCHEMBL30166463 | 0.84 | KDM4E (0.49) | KDM4ENPC1RAB9AHPGDSMN1; SMN2 | |
| SCHEMBL11826212 | 0.84 | CYP1A1 (0.50) | CDC25BKDM4EHPGDSMN1; SMN2ALDH1A1 | |
| SCHEMBL11834181 | 0.83 | CDC25B (0.47) | CDC25BKDM4ENPC1RAB9AHPGD | |
| SCHEMBL11822310 | 0.83 | AURKA (0.49) | CDC25BKDM4ENPC1RAB9AHPGD | |
| SCHEMBL11823673 | 0.83 | AURKA (0.52) | CDC25BKDM4ENPC1RAB9AHPGD | |
| SCHEMBL11836690 | 0.83 | AURKA (0.49) | CDC25BKDM4ENPC1RAB9AHPGD | |
| SCHEMBL11821998 | 0.83 | CYP1A1 (0.49) | CDC25BKDM4ENPC1RAB9AHPGD | |
| SCHEMBL11830081 | 0.83 | AURKA (0.52) | CDC25BKDM4ENPC1RAB9AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3261759-B1 | SELF-HEALING CAPACITOR AND METHODS OF PRODUCTION THEREOF | CAPACITOR SCIENCES INC (US) | 2020-05-06 | — | — | EP | disclosed |
| US-10347423-B2 | Solid multilayer structure as semiproduct for meta-capacitor | CAPACITOR SCIENCES INCORPORATED (US) | 2019-07-09 | — | — | US | disclosed |
| US-10135003-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2018-11-20 | — | — | US | disclosed |
| US-RE47117-E1 | Compensated in-plane switching mode liquid crystal display | CRYSOPTIX K.K. (JP) | 2018-11-06 | — | — | US | disclosed |
| US-20180114641-A1 | SOLID MULTILAYER STRUCTURE AS SEMIPRODUCT FOR META-CAPACITOR | CAPACITOR SCIENCES INCORPORATED | 2018-04-26 | — | — | US | disclosed |
| US-20180114641-A1 | SOLID MULTILAYER STRUCTURE AS SEMIPRODUCT FOR META-CAPACITOR | CAPACITOR SCIENCES INCORPORATED | 2018-04-26 | — | — | US | disclosed |
| US-9916931-B2 | Energy storage devices and methods of production thereof | CAPACITOR SCIENCE INCORPORATED (US) | 2018-03-13 | — | — | US | disclosed |
| US-9916931-B2 | Energy storage devices and methods of production thereof | CAPACITOR SCIENCE INCORPORATED (US) | 2018-03-13 | — | — | US | disclosed |
| US-9852846-B2 | Self-healing capacitor and methods of production thereof | CAPACITOR SCIENCES INCORPORATED (US) | 2017-12-26 | — | — | US | disclosed |
| US-9852846-B2 | Self-healing capacitor and methods of production thereof | CAPACITOR SCIENCES INCORPORATED (US) | 2017-12-26 | — | — | US | disclosed |
| WO-2009130676-A2 | COLOR LIQUID CRYSTAL DISPLAY AND COMPENSATION PANEL | CRYSOPTIX KK (JP) | 2009-10-29 | — | — | WO | disclosed |
| US-20090268136-A1 | Color Liquid Crystal Display and Compensation Panel | CRYSOPTIX KK (JP) | 2009-10-29 | — | — | US | disclosed |
| US-20090161037-A1 | Backlight Module and Liquid Crystal Display Incorporating the Same | CRYSOPTIX KK (JP) | 2009-06-25 | — | — | US | disclosed |
| US-20090161037-A1 | Backlight Module and Liquid Crystal Display Incorporating the Same | CRYSOPTIX KK (JP) | 2009-06-25 | — | — | US | disclosed |
| WO-2009037565-A2 | COLOUR LIQUID CRYSTAL DISPLAY AND PATTERNED COMPENSATION PANEL | CRYSOPTIX K.K. (GB) | 2009-03-26 | — | — | WO | disclosed |
| WO-2008142635-A2 | COMPENSATED IN-PLANE SWITCHING MODE LIQUID CRYSTAL DISPLAY | CRYSOPTIX KK (GB) | 2008-11-27 | — | — | WO | disclosed |
| WO-2007141025-A2 | LIQUID CRYSTAL DISPLAY OPERATING IN A VERTICALLY ALIGNED MODE | CRYSOPTIX K.K. (JP) | 2007-12-13 | — | — | WO | disclosed |
| WO-2007122389-A2 | BACKLIGHT MODULE AND LIQUID CRYSTAL DISPLAY INCORPORATING THE SAME | CRYSOPTIX K.K. (JP) | 2007-11-01 | — | — | WO | disclosed |
| US-4000275-A | BENZIMIDAZO(2,1-B) QUINAZOLIN-12(6H)ONES | ELI LILLY AND COMPANY (US) | 1976-12-28 | — | — | US | disclosed |
| US-4000275-A | BENZIMIDAZO(2,1-B) QUINAZOLIN-12(6H)ONES | ELI LILLY AND COMPANY (US) | 1976-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10135003-B2 | Materials for electronic devices | SCO2, AOC2, HCN2 | CDC25B 1682/4885KDM4E 1163/4885NPC1 2473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.